Fibryga
FIBRYGA
| Product Specs | FIBRYGA |
|---|---|
| Manufacturer Name | Octapharma |
| Indications | FIBRYGA is indicated for the treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia |
| Contraindications | Anaphylactic or severe reactions to FIBRYGA or its components. |
| Viral Safety Process | Solvent/detergent and nanofiltration |
| Product Half-Life | 75.9 ± 23.8 hours |
| Manufacturing Method | Human-Derived Plasma |
| Storage Requirements |
|
| Shelf Life | 30 months from manufactured date |
| Nominal Vial Size & Diluent Volume | 1 g/50 mL |
Return to Manufacturer Name listing Return to Factor Type listing